Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future

Jung Hwan Yu, Han Ah Lee, Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S136-S149. Published online December 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0436

View: 3673 Download: 212 Web of Science: 13 Crossref: 11

Application of transient elastography in nonalcoholic fatty liver disease

Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2020;26(2):128-141. Published online November 8, 2019

DOI: https://doi.org/10.3350/cmh.2019.0001n

View: 13816 Download: 561 Web of Science: 59 Crossref: 63

Imaging findings of mimickers of hepatocellular carcinoma

Tae Kyoung Kim, Eunchae Lee, Hyun-Jung Jang

Clin Mol Hepatol. 2015;21(4):326-343. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.326

View: 41442 Download: 976 Web of Science: 22 Crossref: 24

Liver Imaging

Recent advances in the imaging of hepatocellular carcinoma

Myung-Won You, So Yeon Kim, Kyoung Won Kim, So Jung Lee, Yong Moon Shin, Jin Hee Kim, Moon-Gyu Lee

Clin Mol Hepatol. 2015;21(1):95-103. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.95

View: 10212 Download: 119 Web of Science: 7 Crossref: 7

3

Expression of Caveolin in Hepatocellular Carcinoma: Association with Unpaired Artery Formation and Radiologic Findings

Ha Na Choi, M.S., Kyung Ryoul Kim, Ph.D., Ho Sung Park, M.D., Kyu Yun Jang, M.D., Myoung Jae Kang, M.D., Dong Geun Lee, M.D., Young Kon Kim, M.D. Baik Hwan Cho, M.D. Eun Jung Cha, M.D., Woo Sung Moon, M.D.

Clin Mol Hepatol. 2007;13(3):396-408. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.396

View: 5933 Download: 26 Crossref: 7

1 |

Viewed By 5294	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5240	MAFLD: How is it different from NAFLD?
Viewed By 5140	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3856	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3793	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search